Reduced Sensitivity of Human Platelets to PAF-Acether following Ticlopidine Intake

Authors:
  • CKC. Lalau Keraly
    C. Lalau Keraly
  • DDD. Delautier
    D. Delautier
  • CSC. Sebag
    C. Sebag
  • CBC. Bouloux
    C. Bouloux
  • GMG. Motte
    G. Motte
  • JBJ. Benveniste
    J. Benveniste

Abstract
We investigated in 9 patients the effect of a 7-day treatment by Ticlopidine (250 mg b.i.d.) on washed platelets activation by PAF-acether in comparison with adenosine 5′-diphosphate (ADP) and arachidonic acid (AA). Aggregations induced by ADP were totally suppressed upon drug administration. AA-induced aggregations were partly but significantly inhibited (p < 0.05). Responses of platelets to PAF-acether before treatment differed from patient to patient. A paired Student’s test and a two-way analysis of variance showed a significant inhibitory effect of Ticlopidine treatment on PAF-acether-induced aggregation. The inhibitory effect of Ticlopidine or its metabolite(s) was evidenced after platelet washing procedure, suggesting a persistent effect of this drug on platelet after administration of the drug has been stopped.